VTRS Viatris

$15.37 -2.35%

Healthcare · Pharmaceutical Preparations

Viatris (VTRS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $17.9 billion. Shares last traded at $15.37, 12.3% below their 52-week high. Over the past year the stock is up 75.6%. Net profit margin is -24.7%, below the peer median of -0.1%. Revenue declined 3.0% year over year. The shares yield 5.5% in dividends.

Market Cap

$17.9B

Shares Out

1.16B

EPS (TTM)

$-7.68

P/E Ratio

—

P/S Ratio

1.26

P/B Ratio

1.22

Dividend / Share

$0.84

Dividend Yield

5.47%

52-Week High

$17.53

52-Week Low

$8.50

Volume

1.3M

Avg Vol (3m)

658,014.841

Performance

-5.76%

-4.95%

+13.77%

+34.12%

YTD

+23.26%

+75.56%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

41.50

SMA (50)

$15.64

SMA (200)

$12.96

Price vs SMA50

-1.73%

Price vs SMA200

+18.58%

ATR (14)

$0.49

Financials

Revenue

$14.3B

Net Income

$-3515M

Gross Margin

35.2%

Operating Margin

-18.7%

Net Margin

-24.7%

Return on Equity

-24.0%

Return on Assets

-9.5%

Current Ratio

1.60

Debt / Equity

0.85

Revenue Growth (YoY)

-3.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.15	2026-05-07
FY 2025	$-3.00	2026-02-26
Q3 2025	$-2.70	2025-11-06
Q2 2025	$-2.58	2025-08-07
Q1 2026	$-2.55	2026-05-07
FY 2025	$-0.53	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

VTRS vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

1.26 / 3.54 med

-64% discount

Net margin vs peers

-24.7% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.